BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25443086)

  • 1. Brainstem lymphoma in a myasthenia gravis patient on azathioprine.
    Termsarasab P; Katirji B
    J Clin Neurosci; 2015 Feb; 22(2):415-8. PubMed ID: 25443086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic involvement of a testicular lymphoma in a patient with myasthenia gravis on long-term azathioprine.
    Barthelmes L; Thomas KJ; Seale JR
    Leuk Lymphoma; 2002 Dec; 43(12):2425-6. PubMed ID: 12613537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual presentation of cerebellar lymphoma.
    Harley B; Shivapathasundram G; Astradsson A; Muthurajah V; Wickremesekera A
    J Clin Neurosci; 2018 Nov; 57():177-180. PubMed ID: 30146400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis.
    Müller-Felber W; Ansevin CF; Ricker K; Müller-Jenssen A; Töpfer M; Goebel HH; Pongratz DE
    Neuromuscul Disord; 1999 Dec; 9(8):604-7. PubMed ID: 10619721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary CNS lymphoma in myasthenic on long-term azathioprine.
    Finelli PF
    J Neurooncol; 2005 Aug; 74(1):91-2. PubMed ID: 16078114
    [No Abstract]   [Full Text] [Related]  

  • 6. [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].
    Braun SA; Helbig D; Frank J; Hanneken S
    Hautarzt; 2012 Oct; 63(10):756-9. PubMed ID: 23008007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of myasthenia gravis and Behçet's disease: A case report.
    Kisabay A; Sari US; Boyaci R; Batum M; Yilmaz H; Selcuki D
    Neurol Neurochir Pol; 2016; 50(4):284-7. PubMed ID: 27375145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
    Cosi V; Lombardi M; Erbetta A; Piccolo G
    Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis.
    Hohlfeld R; Michels M; Heininger K; Besinger U; Toyka KV
    Neurology; 1988 Feb; 38(2):258-61. PubMed ID: 3340289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy].
    Takahashi K; Inoue Y; Matsuda O; Takemura T; Yoshimura A
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):394-8. PubMed ID: 10998921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive treatment for juvenile myasthenia gravis.
    Badurska B; Ryniewicz B; Strugalska H
    Eur J Pediatr; 1992 Mar; 151(3):215-7. PubMed ID: 1601015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis.
    Zhang Z; Wang M; Xu L; Jiang B; Jin T; Shi T; Xu B
    J Clin Neurosci; 2021 Jun; 88():70-74. PubMed ID: 33992207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal hypertension secondary to azathioprine in myasthenia gravis.
    Fonseca V; Havard CW
    Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delayed development of multiple supernumerary teeth in a patient with juvenile myasthenia gravis treated with azathioprine].
    Varela M; García-Camba P; Gutiérrez Mosquera B; García Rosas S; Lorda I
    An Pediatr (Barc); 2014 Sep; 81(3):200-1. PubMed ID: 24315416
    [No Abstract]   [Full Text] [Related]  

  • 15. Remission And relapse of myasthenia gravis on long-term azathioprine: An ambispective study.
    Gupta A; Goyal V; Srivastava AK; Shukla G; Behari M
    Muscle Nerve; 2016 Sep; 54(3):405-12. PubMed ID: 26802912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment options for ocular myasthenia gravis.
    Antonio-Santos AA; Eggenberger ER
    Curr Opin Ophthalmol; 2008 Nov; 19(6):468-78. PubMed ID: 18854691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis.
    Bromberg MB; Wald JJ; Forshew DA; Feldman EL; Albers JW
    J Neurol Sci; 1997 Sep; 150(1):59-62. PubMed ID: 9260858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between myasthenia gravis and extrathymic non-Hodgkin's lymphoma].
    Koussa S; Rustom M
    Rev Neurol (Paris); 2010; 166(8-9):752-3. PubMed ID: 20471662
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.
    Dodd KC; Ahmed R; Ambrose P; Holt JK; Jacob S; Leite MI; Miller JA; San PP; Spillane J; Viegas S; Sussman J
    Neuromuscul Disord; 2024 May; 38():51-57. PubMed ID: 38626662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bronchiolo-alveolar carcinoma complicating myasthenia treated by azathioprine].
    Chatté G; Langevin B
    Rev Mal Respir; 1993; 10(5):468-70. PubMed ID: 8256035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.